BioPharma Credit PLC (BPCR) — Cash Flow Reinvestment Rate
Latest as of June 2025:
0.00x
BioPharma Credit PLC (BPCR) has a Cash Flow Reinvestment Rate of 0.00x as of June 2025, reinvesting $0.00 (capex $0.00 ) from operating cash flow of $33.76 Million. See how leveraged is BioPharma Credit PLC's balance sheet to measure how much of total assets are equity-financed.
Reinvestment Rate
0.00x
(Capex + Investments) / Operating CF
Total Reinvested
$0.00
Capex + Investments
Operating Cash Flow
$33.76 Million
USD
Capital Expenditures
$0.00
USD
BioPharma Credit PLC Cash Flow Reinvestment Rate (2017–2024)
Historical reinvestment intensity for BioPharma Credit PLC across 8 annual periods. Also explore BPCR total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for BioPharma Credit PLC (2017–2024)
Year-by-year capital reinvestment analysis for BioPharma Credit PLC. For live market cap and broader valuation context, see BPCR company net worth.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.35x | $39.07 Million | $111.91 Million | $0.00 | ▲ +2497.0% |
| 2023 | 0.01x | $1.66 Million | $123.18 Million | $0.00 | ▼ -94.9% |
| 2022 | 0.26x | $48.19 Million | $184.28 Million | $0.00 | ▼ -73.4% |
| 2021 | 0.98x | $94.82 Million | $96.44 Million | $0.00 | ▲ +20.3% |
| 2020 | 0.82x | $47.47 Million | $58.07 Million | $0.00 | ▲ +7.2% |
| 2019 | 0.76x | $100.30 Million | $131.52 Million | $0.00 | ▼ -88.3% |
| 2018 | 6.51x | $436.99 Million | $67.14 Million | $0.00 | ▼ -57.7% |
| 2017 | 15.38x | $354.74 Million | $23.07 Million | $0.00 | — |
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow